Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial

被引：0
|
作者：
Branch, Kelley [1 ]
Dagenais, G. [2 ]
Avezum, A. [3 ]
Basile, J. [4 ]
Conget, I. [5 ]
Cushman, W. C. [6 ]
Jansky, P. [7 ]
Lakshmanan, M. [8 ]
Lanas, F. [9 ]
Leitner, L. A. [10 ]
Pais, P. [11 ]
Pogosova, N. [12 ]
Raubenheimer, P. J. [13 ]
Gerstein, H.
Probstfield, J. [14 ]
机构：
[1] Univ Washington, Cardiol, Seattle, WA USA
[2] Quebec Heart & Lung Inst, Quebec City, PQ, Canada
[3] Hosp Alemao Oswaldo Cruz, Sao Paulo, Brazil
[4] Med Univ South Carolina, Charleston, SC 29425 USA
[5] Univ Barcelona, Hosp Clin, Barcelona, Spain
[6] Univ Tennessee, Memphis, TN 38163 USA
[7] Motol Univ Hosp, Prague, Czech Republic
[8] Eli Lilly Co, Indianapolis, IN USA
[9] Univ La Frontera, Temuco, Chile
[10] Univ Toronto, Toronto, ON, Canada
[11] St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India
[12] Natl Med Res Ctr, Cardiol, Moscow, Russia
[13] Univ Cape Town, Cape Town, South Africa
[14] Populat Hlth Res Inst, Hamilton, ON, Canada
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [21] Burden of Cardiovascular or Fatal Outcomes in People With Type 2 Diabetes and Cardiovascular Risk Factors Treated With Dulaglutide a Post Hoc Analysis From the Rewind Trial
    Dagenais, Gilles
    Lakshmanan, Mark C.
    Dyal, Leanne
    Atisso, Charles Messan
    Colhoun, Helen
    Ryden, Lars E.
    Gerstein, Hertzel C.
    [J]. CIRCULATION, 2020, 142
  • [22] Place of Residence and Outcomes of Patients With Heart Failure Analysis From the Telemonitoring to Improve Heart Failure Outcomes Trial
    Bikdeli, Behnood
    Wayda, Brian
    Bao, Haikun
    Ross, Joseph S.
    Xu, Xiao
    Chaudhry, Sarwat I.
    Spertus, John A.
    Bernheim, Susannah M.
    Lindenauer, Peter K.
    Krumholz, Harlan M.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (05): : 749 - U169
  • [23] RENOPROTECTIVE EFFECTS OF CANAGLIFLOZIN VIA LESSENING HYPERINSULINEMIA IN DIABETIC PATIENTS WITH HEART FAILURE: A POST-HOC ANALYSIS OF THE CANDLE TRIAL
    Yamaguchi, Satoshi
    Shimabukuro, Michio
    Tanaka, Atsushi
    Node, Koichi
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 : E137 - E137
  • [24] Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis
    Ferrannini, Giulia
    Mellbin, Linda G.
    Kirabo, Faith
    Ramasundarahettige, Chinthanie
    Gerstein, Hertzel C.
    Ryden, Lars
    [J]. DIABETES CARE, 2022, 45 (10) : E146 - E147
  • [25] Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial
    Khan, S.
    Butler, J.
    Young, R.
    Lewis, B. S.
    Escobedo, J.
    Refsgaard, J.
    Reyes, E.
    Roessig, L.
    Blaustein, R. O.
    Lam, C. S. P.
    Voors, A. A.
    Ponikowski, P.
    Anstrom, K. J.
    Armstrong, P.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [26] Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial
    Jolien Neefs
    Nicoline W. E. van den Berg
    Sébastien P. J. Krul
    S. Matthijs Boekholdt
    Joris R. de Groot
    [J]. American Journal of Cardiovascular Drugs, 2020, 20 : 73 - 80
  • [27] Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial
    Neefs, Jolien
    van den Berg, Nicoline W. E.
    Krul, Sebastien P. J.
    Boekholdt, S. Matthijs
    de Groot, Joris R.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (01) : 73 - 80
  • [28] Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial
    Ferrannini, Giulia
    Maldonado, Juan M.
    Raha, Sohini
    Rao-Melacini, Purnima
    Khatun, Rutaba
    Atisso, Charles
    Shurzinske, Linda
    Gerstein, Hertzel C.
    Ryden, Lars
    Bethel, M. Angelyn
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2023, 57 (01)
  • [29] Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial
    Demissei, Biniyam G.
    Postmus, Douwe
    Liu, Licette C. Y.
    Cleland, John G.
    O'Connor, Christopher M.
    Metra, Marco
    Ponikowski, Piotr
    Teerlink, John R.
    Cotter, Gad
    Davison, Beth A.
    Edwards, Christopher
    Givertz, Michael M.
    Bloomfield, Daniel M.
    Dittrich, Howard C.
    Voors, Adriaan A.
    Hillege, Hans L.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 967 - 975
  • [30] Predictors of congestive heart failure after treatment with an endothelin receptor antagonist: a post-hoc analysis of the ASCEND trial
    Hoekman, J.
    Heerspink, H. J. Lambers
    Mann, J.
    Green, D.
    Viberti, G.
    De Zeeuw, D.
    [J]. DIABETOLOGIA, 2013, 56 : S38 - S38
12345